1. Novo Nordisk to develop new obesity pills as CEO exits Full story
2. FDA approves Novavax COVID-19 shot, adds restrictions Full story
3. Children's Mercy + UAB share how to spot AI-driven employee scams — here.
4. HHS sets pricing targets to lower US drug costs: 6 things to know Full story
5. GSK to acquire liver disease treatment for $2B Full story

6. HEDIS updates still manual? Automate changes with AI, here.
7. AHA warns tariffs could worsen drug shortages, pushes for long-term reform Full story
8. GLP-1s may cut risk of obesity-related cancers: 3 study notes Full story
Becker's Learning Opportunities
9. 6 top RCM trends for 2025 — and what they mean for ASCs: here.
10. How Prisma Health takes on eligibility errors and boosts RCM performance. Learn their strategy here.
11. How 1 system achieved a 149% boost in retirement readiness: here.
|